Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4)

被引:74
作者
Levitt, Pat
Ebert, Philip
Mirnics, Karoly
Nimgaonkar, Vishwajit L.
Lewis, David A.
机构
[1] Vanderbilt Univ, Kennedy Ctr Human Dev, Nashville, TN 37203 USA
[2] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA
[3] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA
[6] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA
关键词
synaptic function; gene-environment; neurodevelopment; RGS proteins; schizophrenia;
D O I
10.1016/j.biopsych.2006.04.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Both genetic and environmental factors have been associated with an increased risk for schizophrenia. These factors are not mutually exclusive; a single gene can be a genetic factor (due to a mutation in the gene sequence) and a target of a physiological response to an environmental stimulus, both with the common endpoint of altered expression of the gene. Regulator of G-protein signaling 4 (RGS4) has been implicated as such a gene from three lines of evidence. First, a subset of genetic studies revealed an association between schizophrenia and non-functional polymorphisms in the RGS4 gene. Second, across the cortical mantle the expression of RGS4 mRATA is decreased in a diagnosis-specific manner in subjects with schizophrenia. Third, neurobiological studies demonstrate that RGS4 is highly responsive to environmental stimuli and capable of modulating the function of G-protein coupled neurotransmitter receptors implicated in schizophrenia. RGS4 is an example of a molecule that may underlie increased vulnerability through either genetic or non-genetic mechanisms, which we suggest may be typical of other genes in a complex, polygenic disorder such as schizophrenia.
引用
收藏
页码:534 / 537
页数:4
相关论文
共 39 条
[21]   Catching up on schizophrenia: Natural history and neurobiology [J].
Lewis, DA ;
Lieberman, JA .
NEURON, 2000, 28 (02) :325-334
[22]   Schizophrenia as a disorder of neurodevelopment [J].
Lewis, DA ;
Levitt, P .
ANNUAL REVIEW OF NEUROSCIENCE, 2002, 25 :409-432
[23]   Effectiveness of antipsychotic drugs in patients with chronic schizophrenia [J].
Lieberman, JA ;
Stroup, TS ;
McEvoy, JP ;
Swartz, MS ;
Rosenheck, RA ;
Perkins, DO ;
Keefe, RSE ;
Davis, SM ;
Davis, CE ;
Lebowitz, BD ;
Severe, J ;
Hsiao, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1209-1223
[24]   Maternal care, hippocampal synaptogenesis and cognitive development in rats [J].
Liu, D ;
Diorio, J ;
Day, JC ;
Francis, DD ;
Meaney, MJ .
NATURE NEUROSCIENCE, 2000, 3 (08) :799-806
[25]   Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex [J].
Mirnics, K ;
Middleton, FA ;
Marquez, A ;
Lewis, DA ;
Levitt, P .
NEURON, 2000, 28 (01) :53-67
[26]   Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia [J].
Mirnics, K ;
Middleton, FA ;
Stanwood, GD ;
Lewis, DA ;
Levitt, P .
MOLECULAR PSYCHIATRY, 2001, 6 (03) :293-301
[27]   Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse [J].
Mirnics, K ;
Middleton, FA ;
Lewis, DA ;
Levitt, P .
TRENDS IN NEUROSCIENCES, 2001, 24 (08) :479-486
[28]   Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia [J].
Miyakawa, T ;
Leiter, LM ;
Gerber, DJ ;
Gainetdinov, RR ;
Sotnikova, TD ;
Zeng, HK ;
Caron, MG ;
Tonegawa, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) :8987-8992
[29]   Bringing order to the glutamate chaos in schizophrenia [J].
Moghaddam, B .
NEURON, 2003, 40 (05) :881-884
[30]  
Ni YG, 1999, J NEUROSCI, V19, P3674